Daiwa Securities Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-192
Closed -$9K 1360
2023
Q2
$9K Hold
192
﹤0.01% 1147
2023
Q1
$6K Hold
192
﹤0.01% 1145
2022
Q4
$6K Buy
+192
New +$6.26K ﹤0.01% 1152

Daiwa Securities Group's DICE Position: Q3 2023 in Review

Daiwa Securities Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 192 shares — an estimated $9K sold.

Daiwa Securities Group first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $9K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Daiwa Securities Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 192 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $9K.
  • Daiwa Securities Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Daiwa Securities Group's DICE Therapeutics, Inc. Common Stock position peaked at $9K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Daiwa Securities Group's 13F filing for Q3 2023, filed 1 Nov 2023.